1. How is the Nasal vaccine doing?
This candidate is unprecedented to inject the vaccine. Unlike traditional vaccines that start a bite in the arm, it will be given in the form of Nasal Spray. It has a double achievement: “It stimulates the first barrier against respiration, stimulates the first barrier against respiration, while promoting the overall immune response, while promoting the overall immune response.
“Koncreeli will stop quickly and prevent the potential of our body in our body”
2. High efficiency in current vaccines?
This is the promise of “total protection” that is worse than the current vaccines. Limit hospitals, reduce the mortality rate, but not really protecting the disease. “Including the current vaccines (including RNMs) is said to be activated by inter-stones: They do not activate high-quality b and t lynphocytes. Listen to scientists.
On the contrary, the intranasal vaccination will promote the speedy and effective protection against the virus, which prevents the body. “Activating the immune cells of Nasal Mucosa, it is likely to overcome the virus (which increases the virus), and our systematic immune system is quickly stopped.
3. When will he be tempted in men?
At the second phase of the clinical trial, the tournious trial will be started at the clinical Investigation Center, and then in the Kochi-Passchaur clinic in the Kochi-Passchaur. 36 Volunteers – 18 to 55 people will attend this first stage – in a good health – The intra-nasal vaccine will evaluate three dose levels of doctors. The first stratum will start the lowest quantity of lowest quantities and then apply the climbing rules. The primary results of this first stage is expected to be 2025 fall.
